CERTARA INC. - COMMON STOCK

Certara Appoints Nancy Killefer and Cynthia Collins as New Independent Board Members

15 Jul 2021 15:30:00 By Nasdaq GlobeNewswire

Certara to Report Second Quarter 2021 Financial Results on August 5, 2021

14 Jul 2021 15:30:00 By Nasdaq GlobeNewswire

Certara Announces New Chief Human Resources Officer

13 Jul 2021 07:00:02 By Nasdaq GlobeNewswire

Certara Announces Update of BaseCase Software, the Company’s Value Communication Platform

08 Jul 2021 07:00:01 By Nasdaq GlobeNewswire

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions

23 Jun 2021 18:00:00 By Nasdaq GlobeNewswire

Certara Appoints Dr. Carol Gallagher as New Independent Board Member

14 Jun 2021 07:00:01 By Nasdaq GlobeNewswire

Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference

20 May 2021 07:00:01 By Nasdaq GlobeNewswire

Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies

13 May 2021 07:00:01 By Nasdaq GlobeNewswire

Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance

06 May 2021 15:15:00 By Nasdaq GlobeNewswire

Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier

04 May 2021 17:15:00 By Nasdaq GlobeNewswire